MetaCap

Quest Diagnostics (DGX) vs Illumina (ILMN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Illumina (ILMN) has outperformed Quest Diagnostics (DGX) over the past year, gaining 55.7% versus a gain of 35.0%. Over five years, DGX leads with a +66.7% price change compared with -46.4% for ILMN. Illumina is the larger company by market cap ($29.15 billion vs $28.42 billion), about 1.0 times the size, while Quest Diagnostics is growing revenue faster (+11.8% vs -0.7%).

On valuation, Quest Diagnostics trades at a lower forward P/E (21.6x vs 31.2x for Illumina). Quest Diagnostics pays a dividend yielding 1.31%, while Illumina does not currently pay one. Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 9.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DGX+35.05%ILMN+55.69%
+144%+64%-17%
Nov 21, 20251 yearNov 20, 2026
DGX+74.00%ILMN-47.75%
+83%-3%-88%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DGX versus ILMN key metrics
MetricDGXILMN
Share price$258.28$192.82
Market cap$28.42B$29.15B
1-day change-0.31%-3.90%
YTD return+48.84%+47.01%
1-year return+35.05%+55.69%
5-year return+66.69%-46.40%
P/E ratio (TTM)25.7333.19
Forward P/E21.5531.19
EPS (TTM)$10.04$5.81
Dividend yield1.31%0.00%
Annual dividend$3.38$0.00
Revenue (latest FY)$11.04B$4.34B
Revenue growth (YoY)+11.78%-0.66%
Net income (latest FY)$992.00M$850.00M
Gross margin33.21%66.08%
Operating margin14.10%18.58%
Net margin8.99%19.57%
52-week high$263.19$309.35
52-week low$171.18$112.65
Distance from 52-week high-1.87%-37.67%
Analyst consensusbuybuy
Avg. price target upside-0.39%+35.59%
Average volume1.03M2.82M
Shares outstanding110.02M151.20M
Employees60,0008,600
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ILMN has outperformed DGX by 20.6 percentage points over the past year.
  • Illumina trades at a higher earnings multiple (33.2x vs 25.7x trailing P/E).
  • Quest Diagnostics offers a meaningfully higher dividend yield (1.31% vs 0.00%).
  • Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 9.0 cents for Quest Diagnostics.
  • Quest Diagnostics grew revenue faster in its latest fiscal year (+11.78% vs -0.66%).

About Quest Diagnostics

DGX stock →

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Health Care · Medical Specialities · 60,000 employees

About Illumina

ILMN stock →

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Health Care · Medical Specialities · 8,600 employees

DGX vs ILMN FAQ

Which is bigger, Quest Diagnostics or Illumina?

Illumina (ILMN) is larger, with a market capitalization of $29.15B compared with $28.42B for Quest Diagnostics (DGX).

Which stock has performed better over the past year, DGX or ILMN?

ILMN returned +55.69% over the past 12 months, compared with +35.05% for DGX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, DGX or ILMN?

DGX has the lower trailing P/E at 25.7, versus 33.2 for ILMN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Quest Diagnostics or Illumina?

Quest Diagnostics pays a dividend yielding 1.31%, while Illumina does not currently pay a regular dividend.

Are Quest Diagnostics and Illumina in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons